$2.1 Billion is the total value of Novo Holdings A/S's 52 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDStotal stk mkt | $500,838,000 | +74.1% | 1,525,550 | 0.0% | 23.88% | +68.5% | |
| SYK | STRYKER CORPORATION | $161,412,000 | +1.8% | 796,941 | 0.0% | 7.70% | -1.4% | |
| CTLT | CATALENT INC | $118,155,000 | -32.6% | 1,632,878 | 0.0% | 5.63% | -34.7% | |
| BAM | Sell | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $102,586,000 | -21.0% | 2,508,830 | -14.1% | 4.89% | -23.5% |
| ASML | Buy | ASML HOLDING N V | $94,189,000 | -7.9% | 226,770 | +5.5% | 4.49% | -10.9% |
| CORT | Buy | CORCEPT THERAPEUTICS INC | $85,324,000 | +42.0% | 3,327,768 | +31.7% | 4.07% | +37.5% |
| CRM | Buy | SALESFORCE.COM, INC. | $83,211,000 | +5.4% | 578,500 | +20.9% | 3.97% | +2.0% |
| STE | STERIS PLC | $77,767,000 | -19.3% | 467,687 | 0.0% | 3.71% | -21.9% | |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $68,279,000 | -47.8% | 1,762,942 | -49.8% | 3.26% | -49.4% |
| CABO | Buy | CABLE ONE INC | $68,264,000 | +19.1% | 80,023 | +79.9% | 3.26% | +15.3% |
| AAPL | APPLE INC | $63,763,000 | +1.1% | 461,379 | 0.0% | 3.04% | -2.1% | |
| Sell | ARCELLX, INC. | $59,912,000 | -17.5% | 3,191,878 | -20.5% | 2.86% | -20.1% | |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $59,746,000 | +34.3% | 6,071,703 | +8.7% | 2.85% | +30.1% |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $48,731,000 | -16.1% | 710,780 | 0.0% | 2.32% | -18.8% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $40,061,000 | -29.6% | 500,827 | 0.0% | 1.91% | -31.9% | |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $35,385,000 | -6.7% | 1,684,193 | -16.9% | 1.69% | -9.7% |
| VERV | Sell | VERVE THERAPEUTICS INC | $31,297,000 | +120.9% | 911,111 | -1.7% | 1.49% | +113.8% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $26,914,000 | +2.3% | 317,500 | 0.0% | 1.28% | -1.0% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $21,924,000 | -22.5% | 2,100,000 | -20.3% | 1.04% | -25.0% |
| BPMC | BLUEPRINT MEDICINES CORP | $20,866,000 | +30.5% | 316,674 | 0.0% | 1.00% | +26.3% | |
| VECT | VECTIVBIO HLDG AG | $20,037,000 | +11.1% | 3,339,484 | 0.0% | 0.96% | +7.5% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $20,016,000 | +61.8% | 100,000 | +17.9% | 0.95% | +56.7% |
| PCVX | VAXCYTE INC | $19,769,000 | +10.3% | 823,705 | 0.0% | 0.94% | +6.8% | |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $18,380,000 | +18.1% | 2,000,000 | -20.9% | 0.88% | +14.4% |
| Sell | MINERVA SURGICAL INC | $17,194,000 | +257.1% | 1,862,877 | -9.1% | 0.82% | +246.0% | |
| INSM | INSMED INC | $16,586,000 | +9.2% | 770,000 | 0.0% | 0.79% | +5.7% | |
| NARI | Buy | INARI MED INC | $15,487,000 | +8.5% | 213,200 | +1.5% | 0.74% | +5.0% |
| LVTX | LAVA THERAPEUTICS NV | $15,206,000 | +54.9% | 3,327,312 | 0.0% | 0.72% | +50.1% | |
| TMCI | TREACE MED CONCEPTS INC | $12,984,000 | +53.9% | 588,308 | 0.0% | 0.62% | +49.2% | |
| SILK | SILK RD MED INC | $12,398,000 | +23.7% | 275,511 | 0.0% | 0.59% | +19.6% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $12,405,000 | +5.3% | 631,627 | 0.0% | 0.59% | +1.9% | |
| RPHM | RENEO PHARMACEUTICALS INC | $11,492,000 | +26.4% | 3,430,377 | 0.0% | 0.55% | +22.3% | |
| ABCL | ABCELLERA BIOLOGICS INC | $11,145,000 | -7.1% | 1,126,915 | 0.0% | 0.53% | -10.2% | |
| NKTX | Sell | NKARTA INC | $10,833,000 | -59.7% | 823,200 | -62.2% | 0.52% | -60.9% |
| INSP | Buy | INSPIRE MED SYS INC | $10,802,000 | +4.8% | 60,900 | +8.0% | 0.52% | +1.6% |
| SGEN | New | SEAGEN INC. | $10,262,000 | – | 75,000 | +100.0% | 0.49% | – |
| RCKT | ROCKET PHARMACEUTICALS INC | $10,100,000 | +16.0% | 632,822 | 0.0% | 0.48% | +12.4% | |
| KNTE | KINNATE BIOPHARMA INC | $9,748,000 | -5.2% | 815,707 | 0.0% | 0.46% | -8.3% | |
| Sell | RALLYBIO CORP | $9,129,000 | +87.5% | 630,921 | -2.2% | 0.44% | +81.2% | |
| IO BIOTECH INC | $8,883,000 | -42.0% | 3,277,932 | 0.0% | 0.42% | -43.8% | ||
| LUNG | PULMONX CORP | $8,506,000 | +13.2% | 510,555 | 0.0% | 0.41% | +9.7% | |
| CYT | Sell | CYTEIR THERAPEUTICS INC | $7,566,000 | -47.7% | 3,940,413 | -18.6% | 0.36% | -49.4% |
| SPRB | SPRUCE BIOSCIENCES INC | $6,185,000 | -21.3% | 4,514,336 | 0.0% | 0.30% | -23.8% | |
| BOLT | Sell | BOLT BIOTHERAPEUTICS INC | $5,482,000 | -40.3% | 3,703,991 | -17.8% | 0.26% | -42.3% |
| KZR | New | KEZAR LIFE SCIENCES INC | $5,152,000 | – | 598,377 | +100.0% | 0.25% | – |
| GLTO | GALECTO INC | $4,721,000 | +9.3% | 2,497,791 | 0.0% | 0.22% | +5.6% | |
| PHVS | Buy | PHARVARIS N V | $4,679,000 | -59.2% | 610,000 | +17.5% | 0.22% | -60.5% |
| GRTX | GALERA THERAPEUTICS INC | $4,279,000 | +33.8% | 2,459,021 | 0.0% | 0.20% | +29.9% | |
| MQ | MARQETA INC | $3,144,000 | -12.2% | 441,558 | 0.0% | 0.15% | -14.8% | |
| SPNE | Sell | SEASPINE HLDGS CORP | $2,987,000 | -23.9% | 525,867 | -24.3% | 0.14% | -26.4% |
| ALGS | ALIGOS THERAPEUTICS INC | $2,145,000 | -9.1% | 1,950,000 | 0.0% | 0.10% | -12.1% | |
| SPRO | SPERO THERAPEUTICS INC | $938,000 | +170.3% | 468,902 | 0.0% | 0.04% | +164.7% | |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -761,205 | -100.0% | -0.16% | – |
| AKUS | Exit | AKOUOS INC | $0 | – | -1,061,990 | -100.0% | -0.24% | – |
| INGN | Exit | INOGEN INC | $0 | – | -462,949 | -100.0% | -0.55% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -565,237 | -100.0% | -0.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.